Intriguingly, several papers identified neoantigen-specific T cells preferentially enriched in the proportion of CD8+ and CD4+ T cells expressing PD-1, even suggesting the monitoring of PD-1+ CD8+ T cells as a non-invasive surrogate of neoantigen-reactive T cells residing within the tumor (70–72). This evidence concerns the gene CD4 and neoplasm.